0B68 Baserga, Renato - Thomas Jefferson University - Thomas Jefferson University

Renato L. Baserga, MD

Contact Dr. Baserga

Kimmel Cancer Center
233 S. Tenth Street, Suite 624 A
Philadelphia, PA 19107

(215) 503-4513
(215) 923-0249 fax

Most Recent Peer-reviewed Publications

  1. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth
  2. The decline and fall of the IGF-I receptor
  3. Nutrient restriction and radiation therapy for cancer treatment: When less is more
  4. The type 1 insulin-like growth factor receptor and resistance to DACH1
  5. Expression of Micro-RNA-145 is regulated by a highly conserved genomic sequence 3' to the pre-miR
  6. Regulation of microRNA-145 by growth arrest and differentiation
  7. Mutual interaction and reciprocal down-regulation between c-met and insulin receptor substrate-1
  8. MicroRNA, cell cycle, and human breast cancer
  9. The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms
  10. Mechanism of growth inhibition by microRNA 145: The role of the IGF-I receptor signaling pathway
  11. Growth inhibition by microRNAs that target the insulin receptor substrate-1
  12. Customizing the targeting of IGF-1 receptor
  13. AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells
  14. The insulin receptor substrate-1: A biomarker for cancer?
  15. Regulation of insulin receptor substrate-1 expression levels by caveolin-1
  16. The role of insulin receptor substrate-1 in the oncogenicity of simian virus 40 T antigen
  17. The role of insulin receptor substrate-1 in transformation by v-src
  18. Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes
  19. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells
  20. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling